Market revenue in 2024 | USD 2.8 million |
Market revenue in 2030 | USD 3.6 million |
Growth rate | 4.3% (CAGR from 2024 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Instruments |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the Latin America infectious respiratory disease diagnostics market based on instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Technological developments are expected to contribute to market growth. In addition, increase in government spending, presence of skilled healthcare professionals, rise in focus of multinational diagnostics companies on the development of advanced & novel IVD products, and increase in patient awareness levels are likely to drive the growth of the infectious respiratory disease diagnostics market in Latin America.
Low awareness about prevention & treatment of infectious diseases in undeveloped areas, high cost of treatment, and lack of favorable reimbursement policies are some of the key factors restraining market growth.
However, rising disposable income and growing consumer awareness are a few factors promoting market growth. Latin America is expected grow at a healthy rate owing to the government initiatives in the case of regulations and reimbursement of the lab tests.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America infectious respiratory disease diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account